This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.



Univercells is dedicated to increasing the availability of vaccines and biotherapeutics to address global health challenges. We are developing turnkey solutions for a series of critical vaccines and biosimilars to enable affordability in low- and moderate-income countries.

To achieve this, we have developed innovative biomanufacturing processes for viral production (vaccines, gene therapy vectors) and antibodies that utilize automated and closed bioprocessing in smaller footprints than conventional processes of similar scale.

Our scale-X™ single-use fixed-bed bioreactor scales up to 600m² and our NevoLine™ intensified and integrated manufacturing platform provides low-cost, large-scale capacity with low capital and operating costs. In addition to our turnkey projects, scale-X bioreactor and NevoLine platform are commercially available for third party use.